Literature DB >> 20036393

Which hottest nodes can predict sentinel lymph node metastasis in breast cancer?

Yao-Lung Kuo1, Wei-Jen Yao, Tsai-Wang Chang.   

Abstract

BACKGROUND: In approximately 80% of breast cancer patients, the hottest sentinel lymph nodes (SLNs) can be used to predict nodal metastasis. We correlate the reliability of using these nodes to predict SLN metastasis with different lymphoscintigraphic patterns in breast cancer.
METHODS: SLN biopsies for T(1-2)N(o) breast cancer were performed on 467 patients. Lymphoscintigraphic patterns were divided into three groups by the number of draining routes using blue dye and radiocolloid and whether the hottest nodes were the first nodes in the channel.
RESULTS: The hottest SLNs detected 78 of 87 (90%) cases of SLN metastasis in the 399 patients with successful labeling of both blue dye and radiocolloid in their SLNs. False-negative rates were 0% (single-channel, first node), 58% (multi-channel, first node), and 71% (zero-channel, 0 hottest nodes) (FNR: SingleChanl versus ZeroChanl, P=0.005 and SingleChanl versus MultiChanl, P=0.037; Fisher's exact test).
CONCLUSIONS: We recommend a preoperative lymphoscintigram to distinguish the subset of breast-cancer patients with a single draining channel and whose hottest node is the first node.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20036393     DOI: 10.1016/j.jss.2009.08.024

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  2 in total

1.  Comparison between preoperative and intraoperative injection of (99m)Tc Dextran-500 for sentinel lymph node localization in breast cancer.

Authors:  Maria C Dambros Gabbi; Paulo R Masiero; Diego Uchoa; Ilza V Moraes; Jorge V Biazus; Maria Ia Edelweiss
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-09-06

2.  Preoperative sentinel lymph node localization in vulvar cancer: preliminary experience with inguinal intradermal contrast-enhanced ultrasound.

Authors:  O Lahtinen; M Eloranta; M Anttila; H Kärkkäinen; R Sironen; R Vanninen; S Rautiainen
Journal:  Eur Radiol       Date:  2017-11-30       Impact factor: 5.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.